Dashboard
Manage Tickers

TLSA Tiziana Life Sciences Ltd

Nasdaq tizianalifesciences.com


$ 1.35 $ -0.08 (-5.56 %)    

Friday, 25-Apr-2025 20:10:37 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ na $ 5.21 (1.11 %)
DIA na $ 0.04 (0.01 %)
SPY na $ 3.95 (0.72 %)
TLT na $ 0.65 (0.74 %)
GLD na $ -3.34 (-1.08 %)
$ 1.36
$ 1.35
-- x --
-- x --
$ 1.35 - $ 1.35
$ 0.54 - $ 1.91
355,547
na
140.2M
$ 0.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

tiziana-life-sciences-announced-that-dosing-has-commenced-at-the-fourth-clinical-site-in-its-ongoing-phase-2-trial-evaluating-intranasal-foralumab-in-patients-with-non-active-secondary-progressive-multiple-sclerosis
Tiziana Life Sciences Announced That Dosin...
04/23/2025 11:08:46

tiziana-life-sciences-announces-dosing-od-new-patients-at-yale-ms-center-which-is-participating-in-phase-2-multiple-sclerosis-trial
Tiziana Life Sciences Announces Dosing Od ...
03/25/2025 12:10:00

tiziana-life-sciences-regains-compliance-with-nasdaq
Tiziana Life Sciences Regains Compliance W...
03/14/2025 12:31:28

tiziana-life-sciences-announces-investigational-new-drug-application-submission-for-phase-2-trial-of-intranasal-foralumab-in-als
Tiziana Life Sciences Announces Investigat...
03/04/2025 13:14:06

 

tiziana-life-sciences-announces-study-published-in-nature-neuroscience-demonstrating-results-for-nasal-anti-cd3-therapy-in-traumatic-brain-injury
Tiziana Life Sciences Announces Study Publ...
02/27/2025 13:19:21

Traumatic brain injury is a leading cause of death and disabilityCurrently, there is no treatment to prevent the long-term effe...

tiziana-life-sciences-announces-nasal-anti-cdc-preclinical-study-for-treating-long-covid-study-is-nearing-completion
Tiziana Life Sciences Announces Nasal Anti...
02/25/2025 13:11:52

tiziana-developing-intranasal-foralumab-therapy-and-enters-into-product-development-agreement-with-renaissance-to-optimize-formulation-and-scale-up-foralumab-for-treating-neurodegenerative-and-inflammatory-diseases
Tiziana Developing Intranasal Foralumab Th...
02/21/2025 13:02:18

tiziana-life-sciences-formulab-featured-on-news-channel
Tiziana Life Sciences Formulab Featured On...
02/11/2025 14:16:37

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/24/2025 12:06:14

tiziana-life-sciences-announces-notable-advances-in-motor-functions-from-nasal-anti-cd3-antibody-studies-for-spinal-cord-injury-treatment
Tiziana Life Sciences Announces Notable Ad...
01/23/2025 20:02:11

Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing brea...

tiziana-life-sciences-announced-its-intention-not-to-engage-in-capital-raising-activities-for-the-immediate-future
Tiziana Life Sciences Announced Its Intent...
01/23/2025 13:58:35

tiziana-life-sciences-announces-discovery-of-new-immune-biomarkers-in-na-spms-patients-treated-with-nasal-foralumab-showing-gene-expression-changes-after-3-months
Tiziana Life Sciences Announces Discovery ...
01/22/2025 21:30:39

Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing brea...

tiziana-life-sciences-announced-findings-on-benefits-of-its-nasal-anti-cd3-monoclonal-antibody-in-sustaining-tissue-homeostasis-and-mitigating-the-side-effects-associated-with-glp-1-agonists-discontinuation
Tiziana Life Sciences Announced Findings O...
01/10/2025 13:07:44

tiziana-life-sciences-announced-that-a-review-article-was-published-in-nature-reviews-neurology-highlighting-the-therapeutic-potential-of-intranasal-foralumab-in-various-neurodegenerative-diseases
Tiziana Life Sciences Announced That A Rev...
01/08/2025 12:15:37

us-stocks-poised-to-open-higher-as-futures-advance-tesla-bumble-lifecore-bio-in-focus
US Stocks Poised To Open Higher As Futures...
01/03/2025 11:42:27

U.S. stock futures were higher on Friday, the slipping in first trading session of 2025. All four index futures advanced in pre...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
12/31/2024 21:05:53

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
12/27/2024 21:05:49

tiziana-life-sciences-doses-first-patient-with-intranasal-foralumab-with-moderate-alzheimers-disease
Tiziana Life Sciences Doses First Patient ...
12/17/2024 12:06:17

tiziana-life-sciences-broadens-phase-2-clinical-trial-for-non-active-secondary-progressive-multiple-sclerosis-to-additional-us-medical-institutions
Tiziana Life Sciences Broadens Phase 2 Cli...
12/04/2024 12:07:46

The trial sites include esteemed institutions across the Northeast of the United States.Additional trial sites include:Yale Uni...

elon-musk-says-amazon-founder-jeff-bezos-urged-tesla-spacex-investors-to-dump-stakes-predicting-trumps-loss
Elon Musk Says Amazon Founder Jeff Bezos U...
11/21/2024 08:26:08

Tesla Inc (NASDAQ: TLSA) and SpaceX, chief executive officer, Elon Musk sparked a new controversy by saying that Jeff Bezos, th...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION